Accession Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$40.1M
- Investors
-
6
Accession Therapeutics General Information
Description
Developer of an immuno-oncology therapeutics platform designed to make oncology therapeutics targeted and potent. The company specializes in immunotherapy that is specific, broad in action to kill all cancer cell variants present and potent in activating the full immune system arsenal local to the tumor, enabling doctors to treat the widespread forms of cancer.
Contact Information
Website
www.accessiontherapeutics.comCorporate Office
- Building 7600, The Quorum
- Alec Issigonis Way, ARC Oxford North
- Oxford OX4 2JZ
- England, United Kingdom
Corporate Office
- Building 7600, The Quorum
- Alec Issigonis Way, ARC Oxford North
- Oxford OX4 2JZ
- England, United Kingdom
Accession Therapeutics Timeline
Accession Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 04-Dec-2025 | $40.1M | Completed | Clinical Trials - General | ||
| 4. Early Stage VC | 11-Sep-2024 | Completed | Clinical Trials - General | |||
| 3. Early Stage VC (Series A) | 26-Oct-2023 | Completed | Clinical Trials - General | |||
| 2. Seed Round | 20-Sep-2021 | $14.9M | $14.9M | Completed | Clinical Trials - General | |
| 1. Accelerator/Incubator | Completed | Clinical Trials - General |
Accession Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Accession Therapeutics Comparisons
Industry
Financing
Details
Accession Therapeutics Competitors (2)
One of Accession Therapeutics’s 2 competitors is Kite Pharma, a Formerly VC-backed company based in Santa Monica, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA |
Accession Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Accession Therapeutics Patents
Accession Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202510959-D0 | Improved viral vectors | Pending | 07-Jul-2025 | ||
| GB-202407113-D0 | Improved adenoviral vectors | Inactive | 18-May-2024 | ||
| GB-202320006-D0 | Oncolytic adenovirus | Inactive | 22-Dec-2023 | ||
| GB-202316383-D0 | Improved adenoviral vectors | Inactive | 26-Oct-2023 | ||
| GB-202218307-D0 | Improved adenoviral vectors | Inactive | 06-Dec-2022 |
Accession Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Accession Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Birk Venture | Venture Capital | Minority | ||
| iGlobe Partners | Venture Capital | Minority | ||
| Primavera Venture Partners | Venture Capital | Minority | ||
| Ro Invest | Venture Capital | Minority | ||
| St. Catherine's College | University | Minority |
Accession Therapeutics FAQs
-
When was Accession Therapeutics founded?
Accession Therapeutics was founded in 2020.
-
Where is Accession Therapeutics headquartered?
Accession Therapeutics is headquartered in Oxford, United Kingdom.
-
What is the size of Accession Therapeutics?
Accession Therapeutics has 45 total employees.
-
What industry is Accession Therapeutics in?
Accession Therapeutics’s primary industry is Drug Discovery.
-
Is Accession Therapeutics a private or public company?
Accession Therapeutics is a Private company.
-
What is Accession Therapeutics’s current revenue?
The current revenue for Accession Therapeutics is .
-
How much funding has Accession Therapeutics raised over time?
Accession Therapeutics has raised $108M.
-
Who are Accession Therapeutics’s investors?
Birk Venture, iGlobe Partners, Primavera Venture Partners, Ro Invest, and St. Catherine's College are 5 of 6 investors who have invested in Accession Therapeutics.
-
Who are Accession Therapeutics’s competitors?
Kite Pharma and Genetix Biotherapeutics are competitors of Accession Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
